20 results on '"Voldborg, Bjørn G."'
Search Results
2. Engineering of pH-dependent antigen binding properties for toxin-targeting IgG1 antibodies using light-chain shuffling
- Author
-
Tulika, Tulika, Ruso-Julve, Fulgencio, Ahmadi, Shirin, Ljungars, Anne, Rivera-de-Torre, Esperanza, Wade, Jack, Fernández-Quintero, Monica L., Jenkins, Timothy P., Belfakir, Selma B., Ross, Georgina M.S., Boyens-Thiele, Lars, Buell, Alexander K., Sakya, Siri A., Sørensen, Christoffer V., Bohn, Markus-Frederik, Ledsgaard, Line, Voldborg, Bjørn G., Francavilla, Chiara, Schlothauer, Tilman, Lomonte, Bruno, Andersen, Jan Terje, and Laustsen, Andreas H.
- Published
- 2024
- Full Text
- View/download PDF
3. Inferring secretory and metabolic pathway activity from omic data with secCellFie
- Author
-
Masson, Helen O., Samoudi, Mojtaba, Robinson, Caressa M., Kuo, Chih-Chung, Weiss, Linus, Shams Ud Doha, Km, Campos, Alex, Tejwani, Vijay, Dahodwala, Hussain, Menard, Patrice, Voldborg, Bjorn G., Robasky, Bradley, Sharfstein, Susan T., and Lewis, Nathan E.
- Published
- 2024
- Full Text
- View/download PDF
4. CHOmics: A web-based tool for multi-omics data analysis and interactive visualization in CHO cell lines.
- Author
-
Lin, Dongdong, Yalamanchili, Hima B, Zhang, Xinmin, Lewis, Nathan E, Alves, Christina S, Groot, Joost, Arnsdorf, Johnny, Bjørn, Sara P, Wulff, Tune, Voldborg, Bjørn G, Zhou, Yizhou, and Zhang, Baohong
- Subjects
Bioinformatics ,Mathematical Sciences ,Biological Sciences ,Information and Computing Sciences - Abstract
Chinese hamster ovary (CHO) cell lines are widely used in industry for biological drug production. During cell culture development, considerable effort is invested to understand the factors that greatly impact cell growth, specific productivity and product qualities of the biotherapeutics. While high-throughput omics approaches have been increasingly utilized to reveal cellular mechanisms associated with cell line phenotypes and guide process optimization, comprehensive omics data analysis and management have been a challenge. Here we developed CHOmics, a web-based tool for integrative analysis of CHO cell line omics data that provides an interactive visualization of omics analysis outputs and efficient data management. CHOmics has a built-in comprehensive pipeline for RNA sequencing data processing and multi-layer statistical modules to explore relevant genes or pathways. Moreover, advanced functionalities were provided to enable users to customize their analysis and visualize the output systematically and interactively. The tool was also designed with the flexibility to accommodate other types of omics data and thereby enabling multi-omics comparison and visualization at both gene and pathway levels. Collectively, CHOmics is an integrative platform for data analysis, visualization and management with expectations to promote the broader use of omics in CHO cell research.
- Published
- 2020
5. Multiplex secretome engineering enhances recombinant protein production and purity.
- Author
-
Kol, Stefan, Ley, Daniel, Wulff, Tune, Decker, Marianne, Arnsdorf, Johnny, Schoffelen, Sanne, Hansen, Anders Holmgaard, Jensen, Tanja Lyholm, Gutierrez, Jahir M, Chiang, Austin WT, Masson, Helen O, Palsson, Bernhard O, Voldborg, Bjørn G, Pedersen, Lasse Ebdrup, Kildegaard, Helene Faustrup, Lee, Gyun Min, and Lewis, Nathan E
- Subjects
CHO Cells ,Animals ,Cricetulus ,Recombinant Proteins ,Biological Products ,Antibodies ,Monoclonal ,Chromatography ,Gene Knockout Techniques ,Synthetic Biology ,High-Throughput Nucleotide Sequencing ,Metabolic Engineering ,Rituximab - Abstract
Host cell proteins (HCPs) are process-related impurities generated during biotherapeutic protein production. HCPs can be problematic if they pose a significant metabolic demand, degrade product quality, or contaminate the final product. Here, we present an effort to create a "clean" Chinese hamster ovary (CHO) cell by disrupting multiple genes to eliminate HCPs. Using a model of CHO cell protein secretion, we predict that the elimination of unnecessary HCPs could have a non-negligible impact on protein production. We analyze the HCP content of 6-protein, 11-protein, and 14-protein knockout clones. These cell lines exhibit a substantial reduction in total HCP content (40%-70%). We also observe higher productivity and improved growth characteristics in specific clones. The reduced HCP content facilitates purification of a monoclonal antibody. Thus, substantial improvements can be made in protein titer and purity through large-scale HCP deletion, providing an avenue to increased quality and affordability of high-value biopharmaceuticals.
- Published
- 2020
6. Combating viral contaminants in CHO cells by engineering innate immunity.
- Author
-
Chiang, Austin WT, Li, Shangzhong, Kellman, Benjamin P, Chattopadhyay, Gouri, Zhang, Yaqin, Kuo, Chih-Chung, Gutierrez, Jahir M, Ghazi, Faezeh, Schmeisser, Hana, Ménard, Patrice, Bjørn, Sara Petersen, Voldborg, Bjørn G, Rosenberg, Amy S, Puig, Montserrat, and Lewis, Nathan E
- Abstract
Viral contamination in biopharmaceutical manufacturing can lead to shortages in the supply of critical therapeutics. To facilitate the protection of bioprocesses, we explored the basis for the susceptibility of CHO cells to RNA virus infection. Upon infection with certain ssRNA and dsRNA viruses, CHO cells fail to generate a significant interferon (IFN) response. Nonetheless, the downstream machinery for generating IFN responses and its antiviral activity is intact in these cells: treatment of cells with exogenously-added type I IFN or poly I:C prior to infection limited the cytopathic effect from Vesicular stomatitis virus (VSV), Encephalomyocarditis virus (EMCV), and Reovirus-3 virus (Reo-3) in a STAT1-dependent manner. To harness the intrinsic antiviral mechanism, we used RNA-Seq to identify two upstream repressors of STAT1: Gfi1 and Trim24. By knocking out these genes, the engineered CHO cells exhibited activation of cellular immune responses and increased resistance to the RNA viruses tested. Thus, omics-guided engineering of mammalian cell culture can be deployed to increase safety in biotherapeutic protein production among many other biomedical applications.
- Published
- 2019
7. Whole-Genome Sequencing of Invasion-Resistant Cells Identifies Laminin α2 as a Host Factor for Bacterial Invasion
- Author
-
van Wijk, Xander M, Döhrmann, Simon, Hallström, Björn M, Li, Shangzhong, Voldborg, Bjørn G, Meng, Brandon X, McKee, Karen K, van Kuppevelt, Toin H, Yurchenco, Peter D, Palsson, Bernhard O, Lewis, Nathan E, Nizet, Victor, and Esko, Jeffrey D
- Subjects
Microbiology ,Biological Sciences ,Biomedical and Clinical Sciences ,Biotechnology ,Human Genome ,Emerging Infectious Diseases ,Genetics ,Infectious Diseases ,2.1 Biological and endogenous factors ,2.2 Factors relating to the physical environment ,Infection ,Animals ,CHO Cells ,Cricetinae ,Cricetulus ,Endocytosis ,Gene Deletion ,Gene Knockout Techniques ,Genetic Complementation Test ,Host-Pathogen Interactions ,Laminin ,Sequence Analysis ,DNA ,Staphylococcus aureus ,Streptococcus agalactiae ,Streptococcus pyogenes ,Biochemistry and cell biology ,Medical microbiology - Abstract
To understand the role of glycosaminoglycans in bacterial cellular invasion, xylosyltransferase-deficient mutants of Chinese hamster ovary (CHO) cells were created using clustered regularly interspaced short palindromic repeat (CRISPR) and CRISPR-associated gene 9 (CRISPR-cas9) gene targeting. When these mutants were compared to the pgsA745 cell line, a CHO xylosyltransferase mutant generated previously using chemical mutagenesis, an unexpected result was obtained. Bacterial invasion of pgsA745 cells by group B Streptococcus (GBS), group A Streptococcus, and Staphylococcus aureus was markedly reduced compared to the invasion of wild-type cells, but newly generated CRISPR-cas9 mutants were only resistant to GBS. Invasion of pgsA745 cells was not restored by transfection with xylosyltransferase, suggesting that an additional mutation conferring panresistance to multiple bacteria was present in pgsA745 cells. Whole-genome sequencing and transcriptome sequencing (RNA-Seq) uncovered a deletion in the gene encoding the laminin subunit α2 (Lama2) that eliminated much of domain L4a. Silencing of the long Lama2 isoform in wild-type cells strongly reduced bacterial invasion, whereas transfection with human LAMA2 cDNA significantly enhanced invasion in pgsA745 cells. The addition of exogenous laminin-α2β1γ1/laminin-α2β2γ1 strongly increased bacterial invasion in CHO cells, as well as in human alveolar basal epithelial and human brain microvascular endothelial cells. Thus, the L4a domain in laminin α2 is important for cellular invasion by a number of bacterial pathogens.ImportancePathogenic bacteria penetrate host cellular barriers by attachment to extracellular matrix molecules, such as proteoglycans, laminins, and collagens, leading to invasion of epithelial and endothelial cells. Here, we show that cellular invasion by the human pathogens group B Streptococcus, group A Streptococcus, and Staphylococcus aureus depends on a specific domain of the laminin α2 subunit. This finding may provide new leads for the molecular pathogenesis of these bacteria and the development of novel antimicrobial drugs.
- Published
- 2017
8. A Consensus Genome-scale Reconstruction of Chinese Hamster Ovary Cell Metabolism
- Author
-
Hefzi, Hooman, Ang, Kok Siong, Hanscho, Michael, Bordbar, Aarash, Ruckerbauer, David, Lakshmanan, Meiyappan, Orellana, Camila A, Baycin-Hizal, Deniz, Huang, Yingxiang, Ley, Daniel, Martinez, Veronica S, Kyriakopoulos, Sarantos, Jiménez, Natalia E, Zielinski, Daniel C, Quek, Lake-Ee, Wulff, Tune, Arnsdorf, Johnny, Li, Shangzhong, Lee, Jae Seong, Paglia, Giuseppe, Loira, Nicolas, Spahn, Philipp N, Pedersen, Lasse E, Gutierrez, Jahir M, King, Zachary A, Lund, Anne Mathilde, Nagarajan, Harish, Thomas, Alex, Abdel-Haleem, Alyaa M, Zanghellini, Juergen, Kildegaard, Helene F, Voldborg, Bjørn G, Gerdtzen, Ziomara P, Betenbaugh, Michael J, Palsson, Bernhard O, Andersen, Mikael R, Nielsen, Lars K, Borth, Nicole, Lee, Dong-Yup, and Lewis, Nathan E
- Subjects
Biochemistry and Cell Biology ,Biological Sciences ,Industrial Biotechnology ,Bioengineering ,Animals ,CHO Cells ,Consensus ,Cricetinae ,Cricetulus ,Genome ,Humans ,Metabolic Networks and Pathways ,Recombinant Proteins ,CHO ,Chinese hamster ovary ,biotherapeutic protein production ,genome-scale model ,metabolic network ,systems biology ,Biochemistry and cell biology - Abstract
Chinese hamster ovary (CHO) cells dominate biotherapeutic protein production and are widely used in mammalian cell line engineering research. To elucidate metabolic bottlenecks in protein production and to guide cell engineering and bioprocess optimization, we reconstructed the metabolic pathways in CHO and associated them with >1,700 genes in the Cricetulus griseus genome. The genome-scale metabolic model based on this reconstruction, iCHO1766, and cell-line-specific models for CHO-K1, CHO-S, and CHO-DG44 cells provide the biochemical basis of growth and recombinant protein production. The models accurately predict growth phenotypes and known auxotrophies in CHO cells. With the models, we quantify the protein synthesis capacity of CHO cells and demonstrate that common bioprocess treatments, such as histone deacetylase inhibitors, inefficiently increase product yield. However, our simulations show that the metabolic resources in CHO are more than three times more efficiently utilized for growth or recombinant protein synthesis following targeted efforts to engineer the CHO secretory pathway. This model will further accelerate CHO cell engineering and help optimize bioprocesses.
- Published
- 2016
9. Independent component analysis of E. coli's transcriptome reveals the cellular processes that respond to heterologous gene expression
- Author
-
Tan, Justin, Sastry, Anand V., Fremming, Karoline S., Bjørn, Sara P., Hoffmeyer, Alexandra, Seo, Sangwoo, Voldborg, Bjørn G., and Palsson, Bernhard O.
- Published
- 2020
- Full Text
- View/download PDF
10. Phage display assisted discovery of a pH‐dependent anti‐α‐cobratoxin antibody from a natural variable domain library.
- Author
-
Tulika, Tulika, Pedersen, Rasmus W., Rimbault, Charlotte, Ahmadi, Shirin, Rivera‐de‐Torre, Esperanza, Fernández‐Quintero, Monica L., Loeffler, Johannes R., Bohn, Markus‐Frederik, Ljungars, Anne, Ledsgaard, Line, Voldborg, Bjørn G., Ruso‐Julve, Fulgencio, Andersen, Jan Terje, and Laustsen, Andreas H.
- Abstract
Recycling IgG antibodies bind to their target antigen at physiological pH in the blood stream and release them upon endocytosis when pH levels drop, allowing the IgG antibodies to be recycled into circulation via FcRn‐mediated cellular pathways, while the antigens undergo lysosomal degradation. This enables recycling antibodies to achieve comparable therapeutic effect at lower doses than their non‐recycling counterparts. The development of such antibodies is typically achieved by histidine doping of their variable regions or by performing in vitro antibody selection campaigns utilizing histidine doped libraries. Both are strategies that may introduce sequence liabilities. Here, we present a methodology that employs a naïve antibody phage display library, consisting of natural variable domains, to discover antibodies that bind α‐cobratoxin from the venom of Naja kaouthia in a pH‐dependent manner. As a result, an antibody was discovered that exhibits a 7‐fold higher off‐rate at pH 5.5 than pH 7.4 in bio‐layer interferometry experiments. Interestingly, no histidine residues were found in its variable domains, and in addition, the antibody showed pH‐dependent binding to a histidine‐devoid antigen mutant. As such, the results demonstrate that pH‐dependent antigen‐antibody binding may not always be driven by histidine residues. By employing molecular dynamics simulations, different protonation states of titratable residues were found, which potentially could be responsible for the observed pH‐dependent antigen binding properties of the antibody. Finally, given the typically high diversity of naïve antibody libraries, the methodology presented here can likely be applied to discover recycling antibodies against different targets ab initio without the need for histidine doping. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
11. Discovery of a human monoclonal antibody that cross-neutralizes venom phospholipase A2s from three different snake genera
- Author
-
Sørensen, Christoffer V., Almeida, José R., Bohn, Markus-Frederik, Rivera-de-Torre, Esperanza, Schoffelen, Sanne, Voldborg, Bjørn G., Ljungars, Anne, Vaiyapuri, Sakthivel, and Laustsen, Andreas H.
- Published
- 2023
- Full Text
- View/download PDF
12. Highly Selective Lysine Acylation in Proteins Using a Lys‐His Tag Sequence.
- Author
-
Kofoed, Christian, Wu, Shunliang, Sørensen, Kasper K., Treiberg, Tuule, Arnsdorf, Johnny, Bjørn, Sara P., Jensen, Tanja L., Voldborg, Bjørn G., Thygesen, Mikkel B., Jensen, Knud J., and Schoffelen, Sanne
- Subjects
CHEMICAL modification of proteins ,ACYLATION ,LYSINE ,AMINO acid sequence ,PROTEINS - Abstract
Chemical modification of proteins has numerous applications, but it has been challenging to achieve the required high degree of selectivity on lysine amino groups. Recently, we described the highly selective acylation of proteins with an N‐terminal Gly‐His6 segment. This tag promoted acylation of the N‐terminal Nα‐amine resulting in stable conjugates. Herein, we report the peptide sequences Hisn‐Lys‐Hism, which we term Lys‐His tags. In combination with simple acylating agents, they facilitate the acylation of the designated Lys Nϵ‐amine under mild conditions and with high selectivity over native Lys residues. We show that the Lys‐His tags, which are 7 to 10 amino acids in length and still act as conventional His tags, can be inserted in proteins at the C‐terminus or in loops, thus providing high flexibility regarding the site of modification. Finally, the selective and efficient acylation of the therapeutic antibody Rituximab, pure or mixed with other proteins, demonstrates the scope of the Lys‐His tag acylation method. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
13. Compartmentalized Proteomic Profiling Outlines the Crucial Role of the Classical Secretory Pathway during Recombinant Protein Production in Chinese Hamster Ovary Cells.
- Author
-
Pérez-Rodriguez, Saumel, Wulff, Tune, Voldborg, Bjørn G., Altamirano, Claudia, Trujillo-Roldán, Mauricio A., and Valdez-Cruz, Norma A.
- Published
- 2021
- Full Text
- View/download PDF
14. Predictive glycoengineering of biosimilars using a Markov chain glycosylation model.
- Author
-
Spahn, Philipp N., Hansen, Anders H., Kol, Stefan, Voldborg, Bjørn G., and Lewis, Nathan E.
- Published
- 2017
- Full Text
- View/download PDF
15. Multiplex genome editing eliminates the Warburg Effect without impacting growth rate in mammalian cells.
- Author
-
Hefzi H, Martínez-Monge I, Marin de Mas I, Cowie NL, Toledo AG, Noh SM, Karottki KJC, Decker M, Arnsdorf J, Camacho-Zaragoza JM, Kol S, Schoffelen S, Pristovšek N, Hansen AH, Miguez AA, Bjorn SP, Brøndum KK, Javidi EM, Jensen KL, Stangl L, Kreidl E, Kallehauge TB, Ley D, Ménard P, Petersen HM, Sukhova Z, Bauer A, Casanova E, Barron N, Malmström J, Nielsen LK, Lee GM, Kildegaard HF, Voldborg BG, and Lewis NE
- Abstract
The Warburg effect is ubiquitous in proliferative mammalian cells, including cancer cells, but poses challenges for biopharmaceutical production, as lactate accumulation inhibits cell growth and protein production. Previous efforts to eliminate lactate production via knockout have failed in mammalian bioprocessing since lactate dehydrogenase has proven essential. However, here we eliminated the Warburg effect in Chinese hamster ovary (CHO) and HEK293 cells by simultaneously knocking out lactate dehydrogenase and regulators involved in a negative feedback loop that typically inhibits pyruvate conversion to acetyl-CoA. In contrast to long-standing assumptions about the role of aerobic glycolysis, Warburg-null cells maintain wildtype growth rate while producing negligible lactate. Further characterization of Warburg-null CHO cells showed a compensatory increase in oxygen consumption, a near total reliance on oxidative metabolism, and higher cell densities in fed-batch cell culture. These cells remained amenable for production of diverse biotherapeutic proteins, reaching industrially relevant titers and maintaining product glycosylation. Thus, the ability to eliminate the Warburg effect is an important development for biotherapeutic production and provides a tool for investigating a near-universal metabolic phenomenon.
- Published
- 2024
- Full Text
- View/download PDF
16. Phage display assisted discovery of a pH-dependent anti-α-cobratoxin antibody from a natural variable domain library.
- Author
-
Tulika T, Pedersen RW, Rimbault C, Ahmadi S, Rivera-de-Torre E, Fernández-Quintero ML, Loeffler JR, Bohn MF, Ljungars A, Ledsgaard L, Voldborg BG, Ruso-Julve F, Andersen JT, and Laustsen AH
- Subjects
- Antigens metabolism, Immunoglobulin G genetics, Hydrogen-Ion Concentration, Peptide Library, Histidine metabolism, Bacteriophages metabolism
- Abstract
Recycling IgG antibodies bind to their target antigen at physiological pH in the blood stream and release them upon endocytosis when pH levels drop, allowing the IgG antibodies to be recycled into circulation via FcRn-mediated cellular pathways, while the antigens undergo lysosomal degradation. This enables recycling antibodies to achieve comparable therapeutic effect at lower doses than their non-recycling counterparts. The development of such antibodies is typically achieved by histidine doping of their variable regions or by performing in vitro antibody selection campaigns utilizing histidine doped libraries. Both are strategies that may introduce sequence liabilities. Here, we present a methodology that employs a naïve antibody phage display library, consisting of natural variable domains, to discover antibodies that bind α-cobratoxin from the venom of Naja kaouthia in a pH-dependent manner. As a result, an antibody was discovered that exhibits a 7-fold higher off-rate at pH 5.5 than pH 7.4 in bio-layer interferometry experiments. Interestingly, no histidine residues were found in its variable domains, and in addition, the antibody showed pH-dependent binding to a histidine-devoid antigen mutant. As such, the results demonstrate that pH-dependent antigen-antibody binding may not always be driven by histidine residues. By employing molecular dynamics simulations, different protonation states of titratable residues were found, which potentially could be responsible for the observed pH-dependent antigen binding properties of the antibody. Finally, given the typically high diversity of naïve antibody libraries, the methodology presented here can likely be applied to discover recycling antibodies against different targets ab initio without the need for histidine doping., (© 2023 The Authors. Protein Science published by Wiley Periodicals LLC on behalf of The Protein Society.)
- Published
- 2023
- Full Text
- View/download PDF
17. Highly Selective Lysine Acylation in Proteins Using a Lys-His Tag Sequence.
- Author
-
Kofoed C, Wu S, Sørensen KK, Treiberg T, Arnsdorf J, Bjørn SP, Jensen TL, Voldborg BG, Thygesen MB, Jensen KJ, and Schoffelen S
- Subjects
- Acylation, Amino Acid Sequence, Peptides chemistry, Lysine, Proteins
- Abstract
Chemical modification of proteins has numerous applications, but it has been challenging to achieve the required high degree of selectivity on lysine amino groups. Recently, we described the highly selective acylation of proteins with an N-terminal Gly-His
6 segment. This tag promoted acylation of the N-terminal Nα -amine resulting in stable conjugates. Herein, we report the peptide sequences Hisn -Lys-Hism , which we term Lys-His tags. In combination with simple acylating agents, they facilitate the acylation of the designated Lys Nϵ -amine under mild conditions and with high selectivity over native Lys residues. We show that the Lys-His tags, which are 7 to 10 amino acids in length and still act as conventional His tags, can be inserted in proteins at the C-terminus or in loops, thus providing high flexibility regarding the site of modification. Finally, the selective and efficient acylation of the therapeutic antibody Rituximab, pure or mixed with other proteins, demonstrates the scope of the Lys-His tag acylation method., (© 2022 Wiley-VCH GmbH.)- Published
- 2022
- Full Text
- View/download PDF
18. A Markov model of glycosylation elucidates isozyme specificity and glycosyltransferase interactions for glycoengineering.
- Author
-
Liang C, Chiang AWT, Hansen AH, Arnsdorf J, Schoffelen S, Sorrentino JT, Kellman BP, Bao B, Voldborg BG, and Lewis NE
- Abstract
Glycosylated biopharmaceuticals are important in the global pharmaceutical market. Despite the importance of their glycan structures, our limited knowledge of the glycosylation machinery still hinders controllability of this critical quality attribute. To facilitate discovery of glycosyltransferase specificity and predict glycoengineering efforts, here we extend the approach to model N-linked protein glycosylation as a Markov process. Our model leverages putative glycosyltransferase (GT) specificity to define the biosynthetic pathways for all measured glycans, and the Markov chain modelling is used to learn glycosyltransferase isoform activities and predict glycosylation following glycosyltransferase knock-in/knockout. We apply our methodology to four different glycoengineered therapeutics (i.e., Rituximab, erythropoietin, Enbrel, and alpha-1 antitrypsin) produced in CHO cells. Our model accurately predicted N-linked glycosylation following glycoengineering and further quantified the impact of glycosyltransferase mutations on reactions catalyzed by other glycosyltransferases. By applying these learned GT-GT interaction rules identified from single glycosyltransferase mutants, our model further predicts the outcome of multi-gene glycosyltransferase mutations on the diverse biotherapeutics. Thus, this modeling approach enables rational glycoengineering and the elucidation of relationships between glycosyltransferases, thereby facilitating biopharmaceutical research and aiding the broader study of glycosylation to elucidate the genetic basis of complex changes in glycosylation.
- Published
- 2020
- Full Text
- View/download PDF
19. The human secretome.
- Author
-
Uhlén M, Karlsson MJ, Hober A, Svensson AS, Scheffel J, Kotol D, Zhong W, Tebani A, Strandberg L, Edfors F, Sjöstedt E, Mulder J, Mardinoglu A, Berling A, Ekblad S, Dannemeyer M, Kanje S, Rockberg J, Lundqvist M, Malm M, Volk AL, Nilsson P, Månberg A, Dodig-Crnkovic T, Pin E, Zwahlen M, Oksvold P, von Feilitzen K, Häussler RS, Hong MG, Lindskog C, Ponten F, Katona B, Vuu J, Lindström E, Nielsen J, Robinson J, Ayoglu B, Mahdessian D, Sullivan D, Thul P, Danielsson F, Stadler C, Lundberg E, Bergström G, Gummesson A, Voldborg BG, Tegel H, Hober S, Forsström B, Schwenk JM, Fagerberg L, and Sivertsson Å
- Subjects
- Humans, Databases, Protein, Proteome metabolism, Proteomics
- Abstract
The proteins secreted by human cells (collectively referred to as the secretome) are important not only for the basic understanding of human biology but also for the identification of potential targets for future diagnostics and therapies. Here, we present a comprehensive analysis of proteins predicted to be secreted in human cells, which provides information about their final localization in the human body, including the proteins actively secreted to peripheral blood. The analysis suggests that a large number of the proteins of the secretome are not secreted out of the cell, but instead are retained intracellularly, whereas another large group of proteins were identified that are predicted to be retained locally at the tissue of expression and not secreted into the blood. Proteins detected in the human blood by mass spectrometry-based proteomics and antibody-based immunoassays are also presented with estimates of their concentrations in the blood. The results are presented in an updated version 19 of the Human Protein Atlas in which each gene encoding a secretome protein is annotated to provide an open-access knowledge resource of the human secretome, including body-wide expression data, spatial localization data down to the single-cell and subcellular levels, and data about the presence of proteins that are detectable in the blood., (Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.)
- Published
- 2019
- Full Text
- View/download PDF
20. Human chitotriosidase CHIT1 cross reacts with mammalian-like substrates.
- Author
-
Larsen T, Yoshimura Y, Voldborg BG, Cazzamali G, Bovin NV, Westerlind U, Palcic MM, and Leisner JJ
- Subjects
- Carbohydrate Conformation, Disaccharides chemistry, Glycolipids chemistry, Glycoproteins chemistry, HEK293 Cells, Humans, Hydrolysis, Kinetics, Nitrophenols chemistry, Substrate Specificity, Hexosaminidases chemistry
- Abstract
Humans do not synthesize chitin, yet they produce a number of active and inactive chitinases. One of the active enzymes is chitotriosidase whose serum levels are elevated in a number of diseases such as Gaucher's disease and upon fungal infection. Since the biological role of chitotriosidase in disease pathogenesis is not understood we screened a panel of mammalian GlcNAc-containing glycoconjugates as alternate substrates. LacNAc and LacdiNAc-terminating substrates are hydrolyzed, the latter with a turnover comparable to that of pNP-chitotriose. Glycolipids or glycoproteins with LacNAc and LacdiNAc represent potential chitinase substrates and the subsequent alteration of glycosylation pattern could be a factor in disease pathogenesis., (Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.